Price range: $70.00 through $175.00
Emerging clinical trials show that this triple-agonist (targeting GLP-1, GIP, and Glucagon receptors) dramatically escalates energy expenditure and fat mobilization, leading to unprecedented rates of body weight reduction and improvements in fatty liver markers.
The products available on this website are intended solely for laboratory research and in vitro or animal development studies, and are not to be used for human consumption, veterinary administration to companion animals or livestock, diagnostic procedures, or therapeutic applications. These statements and products have not been evaluated or approved by Health Canada. They are not intended to diagnose, treat, cure, or prevent any medical condition or disease in humans or animals. By purchasing from this site, the buyer acknowledges and agrees that the materials are classified strictly as research chemicals and that any personal administration, clinical use, or misuse is entirely at their own risk.
